Eli Lilly and Co (LLY) Downgraded by Vetr Inc. to "Strong Sell"
They currently have a $70.44 price target on the stock. Vetr 's price objective points to a potential downside of 16.32% from the stock's current price.
from Biotech News
They currently have a $70.44 price target on the stock. Vetr 's price objective points to a potential downside of 16.32% from the stock's current price.
The most important thing is to improve and not stop. Even if you have taken some course, this does not mean that you are now a guru. You need to constantly practice, learn something new.
0 Comments